Sectors
A man with short dark hair and a beard wearing a blue suit jacket and white shirt, standing in front of a blurred indoor background, representing chicago lawyers specializing in intellectual property law.

Shabbi S. Khan

Partner

Shabbi Khan serves as a co-chair for the Artificial Intelligence (AI), Automation, and Robotics Group within Foley & Lardner’s Manufacturing Sector, is a registered patent attorney, and a member of the Electronics Practice within the firm’s Intellectual Property (IP) department.

Shabbi provides strategic advice on all aspects of IP strategy and enforcement, technology transactions, and licenses. His practice has primarily focused on strategic patent portfolio development, counseling, and management, including preparation and prosecution of patent applications, patent infringement analysis, and validity analysis, primarily in the fields of artificial intelligence (AI) and machine learning, computer software, including cloud and SaaS-based technologies, robotics, medical devices, digital therapeutics, and AI in health care. Shabbi’s technical experience and background, together with his patent prosecution and litigation experience, allows him to quickly understand clients’ technology and products, and prepare high-quality, litigation-ready patents that are aligned with their business objectives.

Shabbi’s practice offers deep experience and a specialty in AI, and he helps clients navigate AI-related business and legal issues, including counseling on copyright infringement issues stemming from the use and training of AI models and providing guidance on the operational implementation of AI solutions. As part of his AI practice, Shabbi counsels companies on technology agreements, such as master service agreements, joint development and collaboration agreements, vendor agreements, and technology use and service agreements with a specific eye toward AI-related issues and data monetization considerations.

Shabbi also performs buy-side IP due diligence during a merger or acquisition or a financing transaction involving venture capital or private equity. Shabbi also advises technology companies undergoing due diligence or preparing for an upcoming transaction.

Representative Experience

  • Advised clients on AI related concerns including the use of generative AI at work
  • Prepared corporate policies relating to the use of AI and prepared checklists and toolkits for companies relating to deployment of AI solutions
  • Conducted legal due diligence for transactions involving an investment in, or acquisition of, AI technology companies
  • Developed patent portfolios for emerging tech companies in a variety of technical areas including:
    • AI and machine learning
    • Medical devices
    • Enterprise Software Solutions
    • Software-related medical device technologies
    • Biotechnology, including data and image processing, analysis, and learning
    • Gaming
    • Robotics
    • Computer engineering, architecture, and networking
    • Internet of Things (IoT), devices, and applications
    • Data management and storage
    • Virtual reality (VR), augmented reality (AR), and mixed reality (MR) technologies
    • Security, cryptography, and encryption
    • Wireless, mobile, and related telecommunications systems

Presentations and Publications

  • Author, “European Medtech Companies: Why a U.S. Centric Patent Strategy is Essential for Long-Term Success,” Health Care Law Today (November 12, 2024)
April 8, 2026 Manufacturing Industry Advisor

4 Risks Supply Chain Leaders Can’t Ignore with Humanoid Robots

Humanoid robots are starting to show up in places where, until very recently, they were science fiction: walking warehouse aisles,...
April 7, 2026 In the News

Shabbi Khan on Gen AI's Increasing Role in Product Design— 'Who is the Inventor?'

Foley & Lardner LLP partner Shabbi Khan was quoted in the TechTarget article, “Generative AI's Role Grows in Manufacturing, But Legal, Technical Risks Remain,” discussing the increasing use of generative AI in manufacturing product design.
October 24, 2025 Events

21st Annual IP Conference

July 11, 2025 In the News

Foley Attorneys Assess Critical IP Considerations for Emerging Medical Device Companies

Foley & Lardner LLP attorneys Shabbi Khan, Nate Beaver, Austin Kim, and Jeff Simon authored the Med Device Online article, "Critical Considerations For IP & Patents For Emerging Medical Device Companies."
A stethoscope lies on top of printed charts and graphs displaying statistical and medical data, symbolizing the intersection of healthcare and intellectual property law.
April 21, 2025 Health Care Law Today

MedTech Round Table: What the Trump Administration Means for Companies and Investors

Foley & Lardner LLP hosted and participated in a MedTech round table of investors and business leaders, including chief executive officers, partners, directors, innovation leads, investment funds managers and partners, and general counsels. There was collective interest in understanding how these MedTech leaders are adjusting to the changing business and regulatory environment under the second Trump administration.
A person types on a laptop with a stethoscope resting on the desk in the foreground, highlighting the intersection of healthcare and intellectual property law.
November 12, 2024 Health Care Law Today

European Medtech Companies: Why a U.S. Centric Patent Strategy is Essential for Long-Term Success

As European medtech companies look to expand their presence in the U.S. market, understanding the intricacies of U.S. patent law becomes increasingly important.